DBX (DBX) shareholder outlines Rule 144 sales and past trades activity

Rhea-AI Filing Summary

A shareholder of DBX, identified as Sarah Schubach, has filed a Form 144 notice to sell 1,168 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of 31,349.12. The shares relate to a planned sale on 01/15/2026 on the NASDAQ, and the filing notes that 182,734,460 common shares are outstanding.

The 1,168 common shares to be sold were acquired on 11/15/2025 as restricted stock units from the issuer. The filing also lists recent activity under a Rule 10b5-1 trading plan, including sales of 1,168 common shares on 12/29/2025 for 32,563.84 and 1,066 common shares on 10/30/2025 for 30,274.40, along with several other 10b5-1 sales during the prior three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1168	31349.12	182734460	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2025	Restricted Stock Units	Issuer			1168	11/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SARAH SCHUBACH 1800 Owens Street San Francisco CA 94158	Common	12/29/2025	1168	32563.84
10b5-1 Sales for SARAH SCHUBACH 1800 Owens Street San Francisco CA 94158	Common	12/15/2025	1168	33112.80
10b5-1 Sales for SARAH SCHUBACH 1800 Owens Street San Francisco CA 94158	Common	12/01/2025	1168	34572.80
10b5-1 Sales for SARAH SCHUBACH 1800 Owens Street San Francisco CA 94158	Common	11/20/2025	1168	34374.24
10b5-1 Sales for SARAH SCHUBACH 1800 Owens Street San Francisco CA 94158	Common	10/30/2025	1066	30274.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the DBX Form 144 filing disclose?

The Form 144 filing discloses that a DBX shareholder, Sarah Schubach, intends to sell 1,168 common shares on the NASDAQ, with an aggregate market value of 31,349.12, and provides details on how these shares were acquired and recent related sales.

How many DBX shares are planned to be sold and when?

The filing indicates a planned sale of 1,168 common shares of DBX, with an approximate sale date of 01/15/2026, to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ.

How were the DBX shares in this Form 144 acquired?

The 1,168 common shares covered by the Form 144 were acquired on 11/15/2025 as restricted stock units from the issuer, with the amount of securities acquired and the date of payment both listed as 1,168 and 11/15/2025, respectively.

What recent 10b5-1 sales has Sarah Schubach made in DBX stock?

The filing lists several Rule 10b5-1 sales, including 1,168 common shares sold on 12/29/2025 for 32,563.84, another 1,168 shares on 12/15/2025 for 33,112.80, and 1,066 shares on 10/30/2025 for 30,274.40, among other transactions over the prior three months.

On which exchange will the DBX shares in this Form 144 be sold?

The Form 144 notes that the 1,168 common shares are expected to be sold on the NASDAQ stock exchange.

What is the aggregate market value and shares outstanding for DBX mentioned in the filing?

For the planned sale of 1,168 common shares, the filing reports an aggregate market value of 31,349.12, and states that 182,734,460 common shares are outstanding.